135 related articles for article (PubMed ID: 1450408)
21. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.
Abdel-Wahab ZA; Osanto S; Darrow TL; Barber JR; Vervaert CE; Gangavalli R; McCallister TJ; Seigler HF
Cancer Gene Ther; 1994 Sep; 1(3):171-9. PubMed ID: 7621248
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines.
Todryk SM; Birchall LJ; Erlich R; Halanek N; Orleans-Lindsay JK; Dalgleish AG
Immunology; 2001 Feb; 102(2):190-8. PubMed ID: 11260324
[TBL] [Abstract][Full Text] [Related]
23. Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy.
Ghazizadeh S; Carroll JM; Taichman LB
J Virol; 1997 Dec; 71(12):9163-9. PubMed ID: 9371574
[TBL] [Abstract][Full Text] [Related]
24. Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vector.
Kim JH; Gong SJ; Yoo NC; Lee H; Shin DH; Uhm HD; Jeong SJ; Cho JY; Rha SY; Kim YS; Chung HC; Roh JK; Min JS; Kim BS
Oncol Rep; 1999; 6(1):49-54. PubMed ID: 9864400
[TBL] [Abstract][Full Text] [Related]
25. Construction and characterization of retroviral vectors for interleukin-2 gene therapy.
Fakhrai H; Shawler DL; Van Beveren C; Lin H; Dorigo O; Solomon MJ; Gjerset RA; Smith L; Bartholomew RM; Boggiano CA; Gold DP; Sobol RE
J Immunother; 1997 Nov; 20(6):437-48. PubMed ID: 9409449
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models.
Tüting T; Gambotto A; Baar J; Davis ID; Storkus WJ; Zavodny PJ; Narula S; Tahara H; Robbins PD; Lotze MT
Gene Ther; 1997 Oct; 4(10):1053-60. PubMed ID: 9415311
[TBL] [Abstract][Full Text] [Related]
27. Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma.
Kircheis R; Küpcü Z; Wallner G; Wagner E
Cytokines Cell Mol Ther; 1998 Jun; 4(2):95-103. PubMed ID: 9681248
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.
Hock H; Dorsch M; Kunzendorf U; Qin Z; Diamantstein T; Blankenstein T
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2774-8. PubMed ID: 8464888
[TBL] [Abstract][Full Text] [Related]
29. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
[TBL] [Abstract][Full Text] [Related]
30. Cytokine gene transduction in tumor cells: interleukin (IL)-2 or IL-4 gene transfer in human melanoma cells.
Melani C; Chiodoni C; Arienti F; Maccalli C; Sule-Suso J; Anichini A; Colombo MP; Parmiani G
Nat Immun; 1994; 13(2-3):76-84. PubMed ID: 8173238
[TBL] [Abstract][Full Text] [Related]
31. Induction of antitumor immunity by combined immunogene therapy using IL-2 and IL-12 in low antigenic Lewis lung carcinoma.
Tanaka M; Saijo Y; Sato G; Suzuki T; Tazawa R; Satoh K; Nukiwa T
Cancer Gene Ther; 2000 Nov; 7(11):1481-90. PubMed ID: 11129290
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules.
Santin AD; Ioli GR; Hiserodt JC; Manetta A; Pecorelli S; DiSaia PJ; Granger GA
Am J Obstet Gynecol; 1996 Feb; 174(2):633-40. PubMed ID: 8623798
[TBL] [Abstract][Full Text] [Related]
34. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally transduced with human B7.1 or B7.2.
Geertsen R; Yue FY; Pavlovic J; Laine E; Dummer R
Adv Exp Med Biol; 1998; 451():179-88. PubMed ID: 10026870
[No Abstract] [Full Text] [Related]
36. Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genes.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):191-201. PubMed ID: 7905286
[TBL] [Abstract][Full Text] [Related]
37. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
[TBL] [Abstract][Full Text] [Related]
38. Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.
Dummer R; Yue FY; Pavlovic J; Geertsen R; Döhring C; Moelling K; Burg G
Br J Cancer; 1998 May; 77(9):1413-9. PubMed ID: 9652756
[TBL] [Abstract][Full Text] [Related]
39. Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferon gamma (IFN gamma) are recognised by T cells while resisting destruction by natural killer (NK) cells.
Zier KS; Gansbacher B
Eur J Cancer; 1996 Jul; 32A(8):1408-12. PubMed ID: 8869107
[TBL] [Abstract][Full Text] [Related]
40. A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response.
Abdel-Wahab Z; Weltz C; Hester D; Pickett N; Vervaert C; Barber JR; Jolly D; Seigler HF
Cancer; 1997 Aug; 80(3):401-12. PubMed ID: 9241074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
